Press Releases

Curebase, LEVEL Announce Clinical Trial to Determine Whether Cannabinoids Can Help Veterans Sleep Better

Curebase, LEVEL Announce Clinical Trial to Determine Whether Cannabinoids Can Help Veterans Sleep Better

eClinical Solutions Enhances elluminate Clinical Data Cloud with RBQM

eClinical Solutions LLC, a global provider of cloud-based enterprise software and software-driven clinical data services that accelerate digital clinical initiatives, announced the inclusion of its Risk-Based Quality Management (RBQM) offering within the elluminate Clinical Data Cloud. With this offering, clinical teams can transform numerous data streams into actionable analytics and statistically significant insights for a holistic, risk-based monitoring approach.

Vanessa Biotech receives approval from Ghana FDA to proceed with Cholera Phase II Clinical Trial

Vanessa Biotech (VB) is a biomedical company founded on the desire to “give hope where none existed” by making an impact on healthcare markets often overlooked. Its continually expanding pipeline of innovative pharmaceuticals, medical devices and consumer and public health products reflects the company’s inventive nature and commitment to delivering solutions that increase access to quality care. The company’s flagship product, Shylicine™, is the first-ever drug developed to treat the rare and lethal microvillus inclusion disease. Vanessa Biotech, a University of Connecticut Technology Incubation Program participant, has global offices in Hungary, Spain, and Germany in addition to its Hamden, Conn. corporate campus.

CPhI Worldwide Report: CMOs will account for four of the five top bio manufacturing capacities in 2025

230 Covid-19 supply agreements known, with demand for larger biocapacity remaining constrained as a consequence of the circa 1000 vaccines in development

Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services

Company plans wide ranging investments and expansions to keep pace with demand driven by macro-changes and diversifying client base

Clinical Ink Acquires Digital Artefacts

Clinical Ink — a global clinical trial data and technology company and leader in eSource and decentralized clinical trial conduct — today announced its acquisition of Digital Artefacts, a digital endpoint-based technology company with an unrivaled modular platform for complex cognitive, behavioral, and physiological data capture.

BROOKS AUTOMATION ANNOUNCES NEW AGREEMENT WITH QTC MANAGEMENT, INC. TO SUPPORT THE MILITARY RESERVE HEALTH READINESS PROGRAM

Brooks Automation has announced that its newly branded Azenta Life Sciences business has been contracted by QTC Management, Inc. to provide the storage and distribution of vaccines to the U.S. Department of Defense.

Noxopharm Announces DARRT-2 Clinical Trial in U.S.

Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its DARRT-2 Phase 2 clinical trial has commenced with patient enrollment in the U.S.

Crucial Data Solutions Announces New Public Patient Registry Feature for Mobile App

CDS’ eClinical platform, TrialKit, now offers sponsors and CROs the ability to create global registries in which the public can self-enroll and participate in studies from their mobile device

BioIVT to Showcase Use of a Sandwich-cultured Human Hepatocyte Model to Study Drug-Drug Interactions

Researchers will describe how they used a transporter-competent SCHH model to investigate the DDI potential of bempedoic acid, a drug indicated for hypercholesterolemia.

MedExecWomen Empowers Women in Leadership Roles in the Medical Device Diagnostics and Digital Health Industries

MedExecWomen, an organization dedicated to empowering women in leadership roles in the medical device, diagnostics, drug delivery, and digital healthcare industries, hosted the second annual MedExecWomen conference on October 26, 2021, in Boston, MA.

Samsung Biologics Reports Strong Second Quarter 2021 Financial Results

Mateo Iglesias Vice President Marketing & Sales Sakura Finetek Europe

Sakura Finetek Europe has announced the appointment of Mr. Mateo Iglesias as Vice President of Marketing & Sales EMEAI.

CluePoints partners with ZS to provide best-in-class RBQM expertise and technology, increasing clinical trial efficiency and improving patient outcomes

CluePoints, the premier provider of risk-based quality management (RBQM) and data oversight software for clinical trials, has partnered with ZS, a global professional services firm with technology and analytics expertise in biopharma, to offer innovative capabilities in portfolio-level performance oversight.  The new partnership pairs a best-in-breed solutions company focused on study-level risk-based management with a pharmaceutical and biotech solutions provider with advanced capabilities in portfolio-level quality and operational oversight.

DFE Pharma Proudly Supports COVID-19 Vaccination Supply in Pakistan

BOC Sciences Offers Pseudouridine and Its Derivatives for RNA Improvement

Noxopharm Preclinical Data Further Supports Anti-Inflammatory Role of Idronoxil in the Treatment of COVID-19

Australian clinical-stage drug development company Noxopharm (ASX:NOX) has reported preclinical data that further supports the role of experimental anti-cancer drug, idronoxil, the active ingredient in Veyonda®, as an anti-inflammatory drug for early-stage COVID-19 treatments.

Certara’s Simcyp™ COVID-19 Vaccine Model Named Finalist in Both the 2021 Citeline Awards and R&D 100 Awards

Certara’s Simcyp COVID-19 Vaccine Model uses biosimulation to improve decision-making and help optimize dosing regimens of COVID-19 vaccines. Certara calibrated its model using the structure of actual COVID-19 vaccines and validated it by replicating the published clinical data. The model, which is incorporated in Certara’s Vaccine Simulator™, addresses important questions such as differences in response with age and ethnicity, optimal timing between doses and expected duration of antibody response.

Histobiolab Involves Extensive Expertise in Providing Tissue Microarray to Satisfy Research Needs

Verana Health Partners with Komodo Health to Give Clinical Researchers Deeper Insight into Real-World Patient Journeys

Pairing Verana Health’s de-identified, outpatient EHR data with robust patient journey insight in Komodo’s Healthcare Map will arm life sciences researchers with complete view of patient encounters with the healthcare system